Get started
Author

Lasse Hjort Jakobsen

Observed names: Jakobsen, Lasse, Jakobsen, Lasse H., Jakobsen, Lasse Hjort, L. Hjort Jakobsen, L. Hjort Kyneb Jakobsen, Lasse H Jakobsen, Lasse H. Jakobsen, Lasse Hjort Jacobsen, Lasse Hjort Kyneb Jakobsen, Lasse Jakobsen
Observed institutions: Karolinska University Hospital, Lund University, Aalborg University Hospital, Sahlgrenska University Hospital, Odense University Hospital, Aarhus University Hospital, Copenhagen University Hospital, Rigshospitalet, Karolinska Institutet, Aalborg University
ORCID: 0000-0001-6575-7686
Observed ORCID: 0000-0001-6575-7686
OpenAlex ID: A5015983097
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study
2017 · Lasse Hjort Jakobsen, Martin Bøgsted, et al. · Journal of Clinical Oncology · 102
Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study
2015 · Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, et al. · Journal of Clinical Oncology · 93
PDF
Sex differences in lymphoma incidence and mortality by subtype: A population‐based study
2022 · Cecilia Radkiewicz, Johanna B. Bruchfeld, et al. · American Journal of Hematology · 90
PDF
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
2023 · Katharine L. Lewis, Lasse H. Jakobsen, et al. · Journal of Clinical Oncology · 49
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
2019 · Jorne Lionel Biccler, Ingrid Glimelius, et al. · Journal of Clinical Oncology · 44
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study
2018 · Jorne L. Biccler, Sandra Eloranta, et al. · JCO Clinical Cancer Informatics · 38
Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue)
2016 · Finn Ebbesen, Poul H. Madsen, et al. · Pediatric Research · 35
On estimating the time to statistical cure
2020 · Lasse H. Jakobsen, Therese M.-L. Andersson, et al. · BMC Medical Research Methodology · 34
PDF
R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients
2016 · Pernille Svendsen, Nitesh Shekhrajka, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 34
Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates
2015 · Finn Ebbesen, Pernille K Vandborg, et al. · Pediatric Research · 33
The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
2016 · Linn Reinholdt, Maria Bach Laursen, et al. · Biomarker Research · 31
PDF
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
2023 · Daniel Tuyet Kristensen, Andreas Kisbye Øvlisen, et al. · Blood Advances · 29
PDF
Clinical presentation and mortality in hospitalized patients aged 80+ years with COVID-19–A retrospective cohort study
2020 · Linda Katharina Karlsson, Lasse Hjort Jakobsen, et al. · Archives of Gerontology and Geriatrics · 29
Relapsed/Refractory International Prognostic Index (R/ R‐IPI ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma
2021 · Matthew J. Maurer, Lasse H. Jakobsen, et al. · American Journal of Hematology · 26
PDF
Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population‐based study
2020 · Lasse Hjort Jakobsen, Anne Stidsholt Roug, et al. · British Journal of Haematology · 26
PDF
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study
2017 · Henrik Cederleuf, Lasse Hjort Jakobsen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 25
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients
2020 · Lasse H. Jakobsen, Fredrik Ellin, et al. · British Journal of Haematology · 24
PDF
Mental health among patients with non‐Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators
2022 · Andreas Kiesbye Øvlisen, Lasse Hjort Jakobsen, et al. · American Journal of Hematology · 23
PDF
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
2020 · Joachim Baech, Steen Moeller Hansen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 23
Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients
2020 · Andreas K. Øvlisen, Lasse H. Jakobsen, et al. · Cancer Medicine · 22
PDF
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study
2021 · Andreas K. Øvlisen, Lasse H. Jakobsen, et al. · Journal of Clinical Oncology · 20
Estimating the loss of lifetime function using flexible parametric relative survival models
2019 · Lasse H. Jakobsen, Therese M.-L. Andersson, et al. · BMC Medical Research Methodology · 18
Generalized parametric cure models for relative survival
2020 · Lasse Hjort Jakobsen, Martin Bøgsted, et al. · Biometrical Journal · 15
Fitting parametric cure models in R using the packages cuRe and rstpm2
2022 · Rasmus Kuhr Jensen, Mark Clements, et al. · Computer Methods and Programs in Biomedicine · 14
PDF
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
2022 · Rebecca J. Lee, Oskar Wysocki, et al. · JCO Clinical Cancer Informatics · 14
PDF
Works count: 99
Citation count: 1,077
H-index: 20
I10-index: 31
Year
Topic
Type